4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-054577
Chief Medical Officer sold 5,000 shares at an average $49.58 ($247,879)
- Chief Medical Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2021-09-01 | Option exercise | +5,000 | $1.53 | $7,650 | 114,277 | D |
| Pang Phillip Chief Medical Officer | 2021-09-01 | Sale | −1,888 | $48.72 | $91,986 | 112,389 | D |
| Pang Phillip Chief Medical Officer | 2021-09-01 | Sale | −1,005 | $49.40 | $49,642 | 111,384 | D |
| Pang Phillip Chief Medical Officer | 2021-09-01 | Sale | −2,107 | $50.43 | $106,250 | 109,277 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2021-09-01 | Option exercise · Employee Stock Option (Right to Buy) | −5,000 | 77,591 | D | ||
| Open-market sales · 5,000 sh · avg $49.58 · $247,879 | |||||||
Loading xslF345X03/doc4.xml…